CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells.

MLA

Jin, Linhua, et al. “CXCR4 Up-Regulation by Imatinib Induces Chronic Myelogenous Leukemia (CML) Cell Migration to Bone Marrow Stroma and Promotes Survival of Quiescent CML Cells.” Molecular Cancer Therapeutics, vol. 7, no. 1, Jan. 2008, pp. 48–58. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-07-0042.

APA

Jin, L., Tabe, Y., Konoplev, S., Xu, Y., Leysath, C. E., Lu, H., Kimura, S., Ohsaka, A., Rios, M.-B., Calvert, L., Kantarjian, H., Andreeff, M., & Konopleva, M. (2008). CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Molecular Cancer Therapeutics, 7(1), 48–58. https://doi.org/10.1158/1535-7163.MCT-07-0042

Chicago

Jin, Linhua, Yoko Tabe, Sergej Konoplev, Yuanyuan Xu, Clinton E Leysath, Hongbo Lu, Shinya Kimura, et al. 2008. “CXCR4 Up-Regulation by Imatinib Induces Chronic Myelogenous Leukemia (CML) Cell Migration to Bone Marrow Stroma and Promotes Survival of Quiescent CML Cells.” Molecular Cancer Therapeutics 7 (1): 48–58. doi:10.1158/1535-7163.MCT-07-0042.